98
Views
6
CrossRef citations to date
0
Altmetric
Original Research

Efficacy and safety of tafluprost 0.0015% – retrospective analysis of real-world data from the Philippines

&
Pages 1627-1634 | Published online: 27 Aug 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Ngamkae Ruangvaravate, Karnthida Choojun, Benjawan Srikulsasitorn, Jatupol Chokboonpiem, Dechathon Asanatong & Supaporn Trakanwitthayarak. (2020) Ocular Surface Changes After Switching from Other Prostaglandins to Tafluprost and Preservative-Free Tafluprost in Glaucoma Patients. Clinical Ophthalmology 14, pages 3109-3119.
Read now

Articles from other publishers (4)

Ju-Kuo Lin, Fu-Tsung Wei, Yi-Chun Liu & Yung-Chang Yen. (2022) Real-World Efficacy and Safety of Tafluprost in Primary Open-Angle Glaucoma Patients with Corneal Disorders: A Taiwan Experience. Journal of Ophthalmology 2022, pages 1-7.
Crossref
Xinghuai Sun, Qinghuai Liu, Xin Tang, Ke Yao, Yan Li, Jin Yang, Mingchang Zhang, Huiping Yuan, Yan Zheng, Weining Li & Huacong Peng. (2022) Effectiveness and safety of tafluprost in primary open-angle glaucoma and ocular hypertension: a post-marketing phase IV study in China. BMC Ophthalmology 22:1.
Crossref
Joseph Anthony Tumbocon, Tina T Wong, Thanendthire Sangapillai, Yung-Chang Yen, Sang-Woo Park, Hsien Han Lim & Ngamkae Ruangvaravate. (2022) A Pooled Assessment of Ocular Surface Disease After Switching from Preserved Prostaglandins to Tafluprost Across Six Countries in Asia. Clinical Ophthalmology Volume 16, pages 2669-2676.
Crossref
Prin Rojanapongpun & Visanee Tantisevi. 2021. Primary Angle Closure Glaucoma (PACG). Primary Angle Closure Glaucoma (PACG) 31 44 .